CJC 1295/IPA 7.5/10mg
Growth hormone secretagogue for routine and vitality support.
Best For
Layering into an existing wellness routine
What to Review
Compare fit, dosage, and route this formula into a simple routine before checkout.
Secure in-site checkout flow with a focused cart review before order submission
About This Formula
CJC-1295 is a modified analogue of Growth Hormone-Releasing Hormone (GHRH) with a Drug Affinity Complex (DAC) that significantly extends its half-life compared to native GHRH. It stimulates the pituitary gland to release growth hormone in a physiologically patterned way. Ipamorelin is a selective Growth Hormone Releasing Peptide (GHRP) that triggers GH release with minimal effect on cortisol or prolactin — a key differentiator from older GHRPs like GHRP-2 or GHRP-6. Used in combination, the two peptides are studied for synergistic GH pulse amplification, with research interest in body composition, sleep quality, and recovery support.
Key Points
- CJC-1295 with DAC: extended-release GHRH analogue for sustained pituitary stimulation
- Ipamorelin: selective GHRP with minimal cortisol and prolactin side effects
- Combination studied for synergistic GH release and body composition support
- Research interest in sleep quality improvement and recovery enhancement
Administration
Subcutaneous injection. Often dosed in the evening to align with natural GH pulsatility during sleep. Requires reconstitution with bacteriostatic water.
Routine Notes
Commonly layered into a metabolic or recovery stack. Evening timing is often used to take advantage of the natural overnight GH pulse. Review dosing context with a healthcare professional before use.